biotech · Chronic Peripheral Neuropathy Pain in Diabetics · Diabetic Peripheral Neuropathy · XTLB
XTL BIOPHARMACEUTICALS
XTL BIOPHARMACEUTICALS LTD
XTL Biopharmaceuticals is a biotech organization headquartered in Raanana, USA. It trades on NYSE under ticker XTLB. Primary therapeutic focus areas include Chronic Peripheral Neuropathy Pain in Diabetics, Diabetic Perip
Raanana, USA HQ
1993 Founded
3 Employees
Public company Type
XTLB · NYSE Ticker
Company details
- Status
- Public
- HQ
- Raanana, USA
- Founded
- 1993
- Employees
- 3
- Programs
- 4
- Drugs
- 1
- Patents
- 7
XTL-2125
Phase 1 · small molecule · Chronic Hepatitis C Virus Infection
XTL-2125 for Chronic Hepatitis C Virus Infection is a Phase 1 program (small_molecule) at XTL BIOPHARMACEUTICALS LTD with 1 ClinicalTrials.gov record(s).
Internal code 200517-HMO-CTIL
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- XTL BIOPHARMACEUTICALS LTD
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Chronic Hepatitis C Virus Infection
- Status
- terminated
- Trials
- 1